ADAPY stock
Adaptimmune Therapeutics plc (ADAPY) valuation · rev $178.0M
Adaptimmune Therapeutics plc (ADAPY) rev $178.0M.
| Metric | Value |
|---|---|
| Market cap | $9.5M |
| Revenue | $178.0M |
| P/S | 0.1 |
| P/B | 2.7 |
ADAPY valuation FAQ
What is ADAPY's market cap?
Adaptimmune Therapeutics plc (ADAPY) market cap is $9.5M on the latest cached fundamentals snapshot.
What is ADAPY's latest revenue?
Latest cached Adaptimmune Therapeutics plc (ADAPY) revenue was $178.0M. Statements: https://lician.com/financials/adapy
What is ADAPY's price-to-sales ratio?
Adaptimmune Therapeutics plc (ADAPY) price-to-sales (P/S) is 0.1, cached market cap $9.5M divided by revenue $178.0M.
What is ADAPY's price-to-book ratio?
Adaptimmune Therapeutics plc (ADAPY) price-to-book (P/B) is 2.7 on the latest cached fundamentals snapshot.
How many ADAPY valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Adaptimmune Therapeutics plc (ADAPY): Market cap, Revenue, P/S, and P/B.
Where is ADAPY valuation listed?
Cached valuation multiples for Adaptimmune Therapeutics plc (ADAPY) are listed at https://lician.com/valuation/adapy.
Not investment advice. Figures as filed or reported, not a live feed.